CRP and type 2 diabetes mellitus: The circulating markers of inflammation (e.g., TNF-α and IL-6) and acute-phase reactants (e.g., CRP) are considered strong predictors of the development of type 2 diabetes and the possible associated cardiovascular complications (31).